Global leadership Septodont is a world leader in dental anesthesia with high annual production (600 million cartridges) and a long-standing history since 1932, indicating strong market reach and potential for expanded distribution and premium product partnerships.

R&D and Biotech Active investment in R&D and biocompatible therapeutics (Biodentine and Bioroot RCS) based on ABS Technology creates cross-sell opportunities into endodontics, restorative dentistry, and bioceramic clinical applications.

Strategic partnerships Recent and ongoing collaborations with Dentroid on Nuralyte technology and with Micro-Mega for GenENDO distribution signal openness to co-development and regional expansion, presenting avenues for joint ventures, licensing, or regional sales partnerships.

Sustainability focus Ambitious environmental program to cut GHG emissions by 50 in scopes 1 and 2 by 2032 and alignment for scope 3 with Paris Agreement indicates a sustainability narrative that can be leveraged in procurement conversations and to win RFPs prioritizing ESG.

Growth channels Active geographic and channel expansion through European, UK, Middle East, and Africa distribution partnerships and ongoing global development initiatives present multiple touchpoints for pediatric, general dental, and specialty practices seeking reliable supply and innovative solutions.